Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.

Surgery - 1 Jan 2024

Tumati Abhinay, Egan Caitlin E, Lee-Saxton Yeon J, Marshall Teagan E, Lee Joyce, Jain Kavita, Heymann Jonas J, Gokozan Hamza, Azar Sara Abou, Schwarz Jason, Keutgen Xavier M, Laird Amanda M, Beninato Toni, Zarnegar Rasa, Fahey Thomas J, Finnerty Brendan M

Abstract excerpt

BACKGROUND: Molecular testing guides the management of cytologically indeterminate thyroid nodules. We evaluated the real-world clinical benefit of a commercially available thyroid mutation panel plus microRNA risk classifier in classifying RAS-mutated nodules. METHODS: We performed a subgroup analysis of the results of molecular testing of Bethesda III/IV nodules using the ThyGenX/ThyGeNEXT-ThyraMIR platform at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Thyroid Neoplasms

Share to Thyroid Nodule

Source

Identifiers

PMID: 37907382
DOI: 10.1016/j.surg.2023.07.042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.PMID 37907382Read ↗

Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.Semantic proximity Read ↗

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.Semantic proximity Read ↗

Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules.Semantic proximity Read ↗

Multiplatform molecular test performance in indeterminate thyroid nodules.Semantic proximity Read ↗

How genetics changed or will change the therapy in thyroid nodules with indeterminate cytology?Semantic proximity Read ↗

Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort.Semantic proximity Read ↗

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.Semantic proximity Read ↗

Molecular Testing for Indeterminate Thyroid Nodules: Association of Negative Predictive Value With Nodule Size.Semantic proximity Read ↗

Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.Semantic proximity Read ↗

The actual and future role of molecular tests in thyroid pathology.Semantic proximity Read ↗

RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology-histology correlation.Semantic proximity Read ↗

Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule SizeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.